Apollo Global Management is reportedly in discussions to acquire Johnson & Johnson’s orthopedics unit, DePuy Synthes, in a deal potentially worth $20 billion. J&J has been exploring options for the unit, which generated $9.3 billion in 2025 but faces lawsuits, including a potential spin-off into a publicly traded company. This move aligns with J&J's strategy to focus on higher-growth healthcare segments and follows increased private equity interest in the healthcare sector.

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against LENZ Therapeutics, Inc. (LENZ) following a significant drop in its stock price. This decline occurred after the company reported disappointing Q2 2026 financial results, with organic product sales of its VIZZ eye drop coming in flat, and Bank of America subsequently downgrading the stock and lowering its price target due to a slower-than-expected commercial launch. The firm encourages investors who purchased LENZ securities to contact them for more information regarding the investigation.

Kaspi.kz (KSPI) stock is experiencing volatility as traders take profits following a recent rally. The earlier surge was due to a new KZT 1,000 per share dividend and an increased stake in Hepsiburada, a Turkish e-commerce company. While the company's digital ecosystem offers long-term growth potential, rising costs and regulatory demands could pressure its margins.

AM Best has revised the outlooks to negative from stable for Kemper Corporation and its property/casualty and life subsidiaries, while affirming their existing credit ratings. This change reflects earnings deterioration in Kemper P&C, primarily due to exposure to the challenging California auto insurance market and increased financial leverage at the parent company level. Despite sequential improvements in underwriting results and ongoing rate increases, profitability remains a concern, particularly after California's increase in auto insurance liability limits impacted claim severity.

Invitation Home (NYSE: INVH) has declared a quarterly dividend of $0.30 per share, payable on October 16th to shareholders of record on September 24th, representing an annualized yield of 4.4%. Although the current payout ratio of 141.2% exceeds earnings, analysts anticipate improved dividend coverage next year with an expected payout ratio of 60.6%. The company recently reported strong quarterly earnings of $0.51 EPS, surpassing estimates, and a 9.7% year-over-year revenue increase.

eBay CEO Jamie Iannone sold 22,220 shares of eBay stock worth approximately $2.3 million. This transaction was executed under a pre-established Rule 10b5-1 plan, indicating it was not a discretionary sale based on a bearish outlook. Following the sale, Iannone still retains a significant stake in the company, maintaining alignment with shareholder interests.

Over the past 15 years, Home Depot (NYSE: HD) has demonstrated strong market outperformance, achieving an annualized return of 15.77%. An initial investment of $1000 in Home Depot stock 15 years ago would now be valued at $8,920.54, illustrating the significant impact of compounded returns. The article emphasizes that Home Depot's market capitalization currently stands at $308.16 billion.

Jack in the Box has introduced a "Simpsons Treehouse of Horror" menu, featuring character-driven items and spooky flavors for a limited time. The lineup includes a "Munchie Meal of Horror" with choice of burgers or chicken sandwiches, along with tacos, curly fries, a drink, and a collectible glow-in-the-dark cup, all served in a themed box. This collaboration aims to leverage pop culture fandom and seasonal themes to drive customer engagement and create novelty through collectible packaging and unique sauces like the "Spooky Simpsons Sauce."

Intelligent Bio Solutions Inc. (NASDAQ:INBS) announced an increase in its total outstanding common shares to 3,316,803, following the exercise of prefunded warrants and the issuance of restricted common stock. This update was disclosed in an SEC filing. The company also recently initiated an Interference Study for its Intelligent Fingerprinting Drug Screening System, a crucial step for FDA 510(k) submission.

This article reports on the filing of a Form 8K by Professional Diversity Network Inc. on September 11. It's a brief announcement indicating a regulatory filing by the company. The article also provides stock performance data for IPDN, which is down 13.39%.